Cancer cells often exhibit increased uptake and metabolism of BCAAs to sustain their rapid growth and proliferation, involving increased expression and activity of enzymes like BCAT1 [22], which catalyzes the reversible transamination reaction between BCAAs and α-ketoglutarate, yielding their respective α-keto acids and glutamate [23]. Here, BCAT1 is linked to cancer.